Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum TechnologyNovember 19, 2025 3:15 AM EST | Source: Defence Therapeutics Inc.Montreal, Quebec--(Newsfile Corp. - November 19, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation antibody-drug conjugate ("ADC"), is pleased to announce a major step forward in the fight against cancer that goes beyond the A ...